Skip to main content
Advicenne logo

Advicenne — Investor Relations & Filings

Ticker · ALDVI ISIN · FR0013296746 LEI · 969500YT5VMEYAYODW34 PA Manufacturing
Open in API
Filings indexed 259 across all filing types
Latest filing 2020-12-10 Regulatory Filings
Country FR France
Listing PA ALDVI

About Advicenne

https://advicenne.com

Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release dated December 10, 2020, announcing that Advicenne received a positive opinion from the CHMP (Committee for Medicinal Products for Human Use) of the EMA recommending approval for its drug ADV7103. This is a significant corporate event related to regulatory/drug approval status, but it is not a formal regulatory filing like a 10-K, nor is it a transcript, an earnings release, or a management discussion. It is an announcement of a major development. Since it is a specific announcement about a regulatory milestone (positive opinion leading to expected Marketing Authorisation), it fits best under the general 'Regulatory Filings' category (RNS) as a significant, non-standard announcement, or potentially as a general 'Capital/Financing Update' (CAP) if the approval is expected to drive immediate commercial activity, but RNS is the most appropriate fallback for specific, non-standard corporate news releases that aren't explicitly covered elsewhere. Given the context of drug approval news, RNS (Regulatory Filings/Announcements) is the best fit among the provided options for a press release detailing a positive CHMP opinion.
2020-12-10 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly cites French regulatory articles (Code commerce and AMF General Regulation) and provides a table detailing the number of shares and voting rights as of November 30, 2020. This type of mandatory periodic disclosure regarding the total share capital and voting rights structure is a specific regulatory filing requirement, often related to capital structure changes or mandatory disclosures following share movements. While it is a specific regulatory disclosure, it does not fit perfectly into the defined categories like DIRS (Director's Dealing), SHA (Share Issue), or POS (Transaction in Own Shares). Since it is a mandatory, periodic regulatory update concerning the capital structure and voting rights, and it is not a full report (like 10-K or IR), the most appropriate general regulatory category is RNS (Regulatory Filings), as it is a specific regulatory announcement that doesn't map cleanly elsewhere, although it is highly specific in nature. Given the options, RNS serves as the best fit for a mandatory, non-standard regulatory update.
2020-12-09 French
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is a press release dated October 27, 2020, announcing that Advicenne has secured a non-dilutive loan facility of €4.3 million guaranteed by the French State. This announcement details a specific financing activity (obtaining a credit agreement/loan) intended to strengthen the company's cash position. This directly aligns with the definition of 'Capital/Financing Update' (Code: CAP), which covers updates on company fundraising or financing activities. It is not an earnings release (ER), an interim report (IR), or a full annual report (10-K). Given the specific nature of the announcement, CAP is the most appropriate classification.
2020-10-27 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 1% confidence The document is a press release dated October 27, 2020, announcing that Advicenne has secured a non-dilutive financing of €4.3 million in the form of a State Guaranteed Loan (PGE) from BNP Paribas and BPI France. This clearly relates to the company's fundraising and capital structure activities. Based on the definitions, the most appropriate category is 'Capital/Financing Update' (CAP). The document is short and is an announcement, not a comprehensive report, confirming it is an update/announcement type filing.
2020-10-27 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly cites French regulatory articles (Code commerce and AMF General Regulation) and provides a table detailing the total number of shares and voting rights as of September 30, 2020. This content directly relates to the calculation and disclosure of voting rights and share capital structure, which aligns best with the definition of a regulatory filing concerning share capital changes or voting rights, although it is a specific monthly disclosure. Given the options, this is a specific regulatory disclosure about the capital structure and voting rights. It is not a general earnings release (ER), an annual report (10-K), or a management discussion (MDA). Since there is no specific code for 'Monthly Voting Rights Disclosure', and it is a mandatory regulatory disclosure, it falls under the general regulatory filing category (RNS) or potentially a specific capital/share announcement. However, the content is a direct disclosure of voting rights and share count, which is a key component of capital structure reporting. Comparing the definitions, 'SHA' (Share Issue/Capital Change) is close, but this is a periodic update on existing shares/votes, not an issuance. 'RNS' (Regulatory Filings) is the most appropriate fallback for mandatory, specific regulatory disclosures that don't fit the other precise categories. Given the nature of the data (total voting rights disclosure), it is a mandatory regulatory filing.
2020-10-13 French
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel
Report Publication Announcement Classification · 1% confidence The document is a short press release (4331 characters) titled "Advicenne annonce la mise en ligne de son rapport financier semestriel 2020" (Advicenne announces the online availability of its 2020 semi-annual financial report). It explicitly states that the report is made available ('mise à disposition') and directs the reader to the company website to find it. This perfectly matches the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of reports, rather than being the comprehensive report itself (which would likely be classified as IR for an interim report, but the announcement nature overrides this based on Rule 2).
2020-09-30 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.